Drug shortage
Extended Release · Upsher-Smith Laboratories, LLC
FDA drug shortage · To Be Discontinued · updated Apr 24, 2025
Key facts
| Generic name | Extended Release, Topiramate Capsule |
|---|---|
| Company | Upsher-Smith Laboratories, LLC |
| Presentation | Qudexy XR, Capsule, Extended Release, 200 mg (NDC 0245-1073-30) |
| Dosage form | Capsule, Extended Release |
| Status | To Be Discontinued |
| Therapeutic category | Neurology |
| Package NDCs | 0245-1073-30 |
| First posted | Apr 24, 2025 |
| Last updated | Apr 24, 2025 |
| Discontinued | Apr 24, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: